suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

Autor: Izzet Altintas, Jesper Eugen-Olsen, Santeri Seppälä, Jens Tingleff, Marius Ahm Stauning, Nora Olsen El Caidi, Sanaá Elmajdoubi, Hejdi Gamst-Jensen, Mette B Lindstrøm, Line Jee Hartmann Rasmussen, Klaus Tjelle Kristiansen, Christian Rasmussen, Jan O Nehlin, Thomas Kallemose, Harri Hyppölä, Ove Andersen

Publikováno v: Biomarker Insights, Vol 16 (2021)

Objectives: Elevated soluble urokinase Plasminogen Activator Receptor (suPAR) is a biomarker associated with adverse outcomes. We aimed to investigate the associations between plasma suPAR levels (testing the cut-offs ⩽4, 4-6, and ⩾6 ng/mL) with

Externí odkaz: https://doaj.org/article/a372f7d0a4a547489c5b936a7c01e65f

Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members

Autor: Hadi, Amer, Werge, Mikkel, Kristiansen, Klaus Tjelle, Pedersen, Ulf Gøttrup, Karstensen, John Gásdal, Novovic, Srdan, Gluud, Lise Lotte

Publikováno v: In Pancreatology June 2020 20(4):665-667

Cardiac arrhythmias in critically ill patients with coronavirus disease 2019: A retrospective population‐based cohort study

Autor: Anne Sofie Andreasen, Steen Pehrson, Hasse Møller-Sørensen, Anders Bastiansen, Klaus Tjelle Kristiansen, Peter Karl Jacobsen, Morten H. Bestle, Christian Hassager, Niels Risum, Mik Wetterslev, Anders Perner, Thomas Mohr, Christian Jons

Publikováno v: Acta Anaesthesiologica Scandinavica

Background Coronavirus disease 2019 (COVID‐19) may be associated with cardiac arrhythmias in hospitalized patients, but data from the ICU setting are limited. We aimed to describe the epidemiology of cardiac arrhythmias in ICU patients with COVID�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47ce9abd88d107c38910d98f2254a647
https://doi.org/10.1111/aas.13806

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

Autor: Anders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, Sheila Nainan Myatra, Bharath Kumar Tirupakuzhi Vijayaraghavan, Maria Cronhjort, Rebecka Rubenson Wahlin, Stephan M. Jakob, Luca Cioccari, Gitte Kingo Vesterlund, Tine Sylvest Meyhoff, Marie Helleberg, Morten Hylander Møller, Thomas Benfield, Balasubramanian Venkatesh, Naomi E. Hammond, Sharon Micallef, Abhinav Bassi, Oommen John, Vivekanand Jha, Klaus Tjelle Kristiansen, Charlotte Suppli Ulrik, Vibeke Lind Jørgensen, Margit Smitt, Morten H. Bestle, Anne Sofie Andreasen, Lone Musaeus Poulsen, Bodil Steen Rasmussen, Anne Craveiro Brøchner, Thomas Strøm, Anders Møller, Mohd Saif Khan, Ajay Padmanaban, Jigeeshu Vasishtha Divatia, Sanjith Saseedharan, Kapil Borawake, Farhad Kapadia, Subhal Dixit, Rajesh Chawla, Urvi Shukla, Pravin Amin, Michelle S. Chew, Christian Aage Wamberg, Neeta Bose, Mehul S. Shah, Iben S. Darfelt, Christian Gluud, Theis Lange, Anders Perner

Publikováno v: Granholm, A, Kjær, M-B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Møller, A, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580–589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Møller, A, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2
Granholm, A, Kjær, M-B N, Munch, M W, Myatra, S N, Vijayaraghavan, B K T, Cronhjort, M, Wahlin, R R, Jakob, S M, Cioccari, L, Vesterlund, G K, Meyhoff, T S, Helleberg, M, Møller, M H, Benfield, T, Venkatesh, B, Hammond, N E, Micallef, S, Bassi, A, John, O, Jha, V, Kristiansen, K T, Ulrik, C S, Jørgensen, V L, Smitt, M, Bestle, M H, Andreasen, A S, Poulsen, L M, Rasmussen, B S, Brøchner, A C, Strøm, T, Khan, M S, Padmanaban, A, Divatia, J V, Saseedharan, S, Borawake, K, Kapadia, F, Dixit, S, Chawla, R, Shukla, U, Amin, P, Chew, M S, Wamberg, C A, Bose, N, Shah, M S, Darfelt, I S, Gluud, C, Lange, T & Perner, A 2022, ' Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia ', Intensive Care Medicine, vol. 48, no. 5, pp. 580-589 . https://doi.org/10.1007/s00134-022-06677-2

PURPOSE: We assessed long-term outcomes of dexamethasone 12 mg versus 6 mg given daily for up to 10 days in patients with coronavirus disease 2019 (COVID-19) and severe hypoxaemia.METHODS: We assessed 180-day mortality and health-related quality of l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a03aca1ede6095b26a7bc6659898e2a

High Mortality Among Patients With Severe COVID-19 and Do-not-intubate Orders Despite Use of Remdesivir and Dexamethasone

Autor: Tamara Theresia Lund, G Kronborg, Simone Bastrup Israelsen, Klaus Tjelle Kristiansen, Nanna Holm, Thomas Benfield, Rikke Krogh-Madsen

Background Moderate to severe respiratory distress among patients with coronavirus disease 2019 (COVID-19) is associated with a high mortality. Dexamethasone and remdesivir were introduced in the second wave of COVID-19 in Denmark. Methods This is a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cf3f3f49d2bdd5249190a42e0dfcb207
https://doi.org/10.21203/rs.3.rs-788108/v1